{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:06:22Z","timestamp":1775307982389,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.100898","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:29:50Z","timestamp":1771028990000},"page":"100898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A \u201cReal-World\u201d Pre-Post Intervention Cohort Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Alexander J.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hachuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-1363","authenticated-orcid":false,"given":"Thomas","family":"Wallach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savanna","family":"Thor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.100898_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/febs.17200","article-title":"The role of the gut microbiome in disorders of gut-brain interaction","volume":"292","author":"Gawey","year":"2025","journal-title":"FEBS J"},{"key":"10.1016\/j.gastha.2026.100898_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1053\/j.gastro.2023.02.033","article-title":"Factor analysis of the Rome IV criteria for major disorders of gut-brain interaction (DGBI) globally and across geographical, sex, and age groups","volume":"164","author":"Hreinsson","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100898_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ueg2.12271","article-title":"Disorders of gut-brain interaction: highly prevalent and burdensome yet under-taught within medical education","volume":"10","author":"Simons","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gastha.2026.100898_bib4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2023.08.010","article-title":"Prevalence and burden of illness of Rome IV irritable bowel syndrome in the United States: results from a nationwide cross-sectional study","volume":"165","author":"Almario","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gastha.2026.100898_bib5","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.14309\/ajg.0000000000002753","article-title":"Healthcare costs of irritable bowel syndrome and irritable bowel syndrome subtypes in the United States","volume":"119","author":"Shin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gastha.2026.100898_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","article-title":"Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis","volume":"264","author":"Fond","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.gastha.2026.100898_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100898_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2017.10.040","article-title":"Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity","volume":"154","author":"Skodje","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gastha.2026.100898_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cgh.2024.03.047","article-title":"All FODMAPs aren't created equal: results of a randomized reintroduction trial in patients with irritable bowel syndrome","volume":"23","author":"Eswaran","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.100898_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2024.02.008","article-title":"Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in irritable bowel syndrome","volume":"167","author":"Van den Houte","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100898_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tifs.2015.01.006","article-title":"Cereal grain fructans: structure, variability and potential health effects","volume":"43","author":"Verspreet","year":"2015","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.gastha.2026.100898_bib12","first-page":"163","article-title":"Fructan prebiotics derived from inulin","volume":"Volume 1","author":"Bosscher","year":"2009"},{"issue":"1","key":"10.1016\/j.gastha.2026.100898_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11894-013-0370-0","article-title":"Dietary fructose intolerance, fructan intolerance and FODMAPs","volume":"16","author":"Fedewa","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gastha.2026.100898_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/680196","article-title":"Effects of exogenous lactase administration on hydrogen breath excretion and intestinal symptoms in patients presenting lactose malabsorption and intolerance","volume":"2014","author":"Ibba","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.gastha.2026.100898_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ajg.2017.245","article-title":"Increasing symptoms in irritable bowel symptoms with ingestion of galacto-oligosaccharides are mitigated by \u03b1-galactosidase treatment","volume":"113","author":"Tuck","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100898_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jgh.13686","article-title":"How to institute the low-FODMAP diet","volume":"32","author":"Barrett","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2026.100898_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5056\/jnm22035","article-title":"How to implement the 3-phase FODMAP diet into gastroenterological practice","volume":"28","author":"Sultan","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.gastha.2026.100898_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.gastha.2022.10.011","article-title":"In vitro efficacy of targeted fermentable oligosaccharides, disaccharides, monosaccharides, and polyols enzymatic digestion in a high-fidelity simulated gastrointestinal environment","volume":"2","author":"Ochoa","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.gastha.2026.100898_bib20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0895-4356(03)00027-1","article-title":"Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials","volume":"56","author":"M\u00fcller-Lissner","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gastha.2026.100898_bib21","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ejim.2013.05.013","article-title":"The brief Visual Analogue Scale for Irritable Bowel Syndrome questionnaire can be used to evaluate psychological well-being in patients with irritable bowel syndrome","volume":"24","author":"Bengtsson","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.gastha.2026.100898_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-11-208","article-title":"Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients","volume":"11","author":"Andrae","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.gastha.2026.100898_bib24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.cgh.2021.07.004","article-title":"Food avoidance and restriction in irritable bowel syndrome: relevance for symptoms, quality of life and nutrient intake","volume":"20","author":"Melchior","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2026.100898_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2020.06.099","article-title":"Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome","volume":"160","author":"Chey","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:11:17Z","timestamp":1775304677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326000191"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100898","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A \u201cReal-World\u201d Pre-Post Intervention Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"100898"}}